[Home ] [Archive]   [ فارسی ]  
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Indexing and Abstracting
Index Medicus for the Eastern Mediterranean Region (IMEMR)
Index Copernicus
ResearchBible
J-Gate
I۲OR
ROAD
CiteFactor
Scientific Indexing Services
SID
Magiran
Google Scholar
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 3, Issue 4 (COVID-19 Supplement 2021) ::
J Mar Med 2021, 3(4): 49-56 Back to browse issues page
Evaluation of Anxiety Caused by COVID-19 in Patients with Multiple Sclerosis: A Cross-Sectional Study on the Second Wave of Coronavirus in Jahrom City, Iran
Ahmad Rastgarian , Navid Kalani , Fatemeh Golestan , Mehrdad Estakhr , Zahra Ghotbi , Naser Hatami , Maryam Jalali *
, jalalimaryam66@yahoo.com
Abstract:   (1644 Views)
Background and Aim: COVID-19 pandemic can be considered an effective factor in increasing physical and psychological manifestations, especially anxiety in patients with multiple sclerosis (MS). Therefore, the aim of this study was to determine the level of anxiety in patients with MS during the COVID-19 pandemic.
Methods: This cross-sectional study was performed in Jahrom city in 2020 during the second wave of coronavirus in Iran. 191 patients with definite MS (multiple sclerosis) were included in the study by the census. Data collection tools included the demographic data questionnaire and Corona Disease Anxiety Scale.
Results: The mean overall score of anxiety in patients with MS during the COVID-19 pandemic in Jahrom was 8 out of 54. The mean score in the dimension of psychological symptoms was 6.4 and in the dimension of physical symptoms was 1.7 out of 27. These scores indicate that the level of anxiety in patients with MS is low.
Conclusion: Patients with MS in Jahrom city are in a good condition in terms of anxiety about COVID-19 disease; which can be a good indication of the low impact of pandemic conditions on the symptoms of patients with MS.
Keywords: Multiple Sclerosis, Anxiety, COVID-19, SARS-CoV-2.
Full-Text [PDF 912 kb]   (1081 Downloads)    
Type of Study: Original Article | Subject: Marine Medicine
Received: 2021/05/18 | Accepted: 2021/08/6 | Published: 2021/09/1
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rastgarian A, Kalani N, Golestan F, Estakhr M, Ghotbi Z, Hatami N et al . Evaluation of Anxiety Caused by COVID-19 in Patients with Multiple Sclerosis: A Cross-Sectional Study on the Second Wave of Coronavirus in Jahrom City, Iran. J Mar Med 2021; 3 (4) :49-56
URL: http://jmarmed.ir/article-1-224-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 3, Issue 4 (COVID-19 Supplement 2021) Back to browse issues page
مجله طب دریا Journal of Marine Medicine
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645